A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
Open Access
- 29 November 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 112 (5), 466-479
- https://doi.org/10.1093/jnci/djz164
Abstract
Risk-prediction models have been proposed to select individuals for lung cancer screening. However, their long-term effects are uncertain. This study evaluates long-term benefits and harms of risk-based screening compared with current United States Preventive Services Task Force (USPSTF) recommendations. Four independent natural history models were used to perform a comparative modeling study evaluating long-term benefits and harms of selecting individuals for lung cancer screening through risk-prediction models. In total, 363 risk-based screening strategies varying by screening starting and stopping age, risk-prediction model used for eligibility (Bach, PLCOm2012, or Lung Cancer Death Risk Assessment Tool [LCDRAT]), and risk threshold were evaluated for a 1950 US birth cohort. Among the evaluated outcomes were percentage of individuals ever screened, screens required, lung cancer deaths averted, life-years gained, and overdiagnosis. Risk-based screening strategies requiring similar screens among individuals ages 55–80 years as the USPSTF criteria (corresponding risk thresholds: Bach = 2.8%; PLCOm2012 = 1.7%; LCDRAT = 1.7%) averted considerably more lung cancer deaths (Bach = 693; PLCOm2012 = 698; LCDRAT = 696; USPSTF = 613). However, life-years gained were only modestly higher (Bach = 8660; PLCOm2012 = 8862; LCDRAT = 8631; USPSTF = 8590), and risk-based strategies had more overdiagnosed cases (Bach = 149; PLCOm2012 = 147; LCDRAT = 150; USPSTF = 115). Sensitivity analyses suggest excluding individuals with limited life expectancies (<5 years) from screening retains the life-years gained by risk-based screening, while reducing overdiagnosis by more than 65.3%. Risk-based lung cancer screening strategies prevent considerably more lung cancer deaths than current recommendations do. However, they yield modest additional life-years and increased overdiagnosis because of predominantly selecting older individuals. Efficient implementation of risk-based lung cancer screening requires careful consideration of life expectancy for determining optimal individual stopping ages.Funding Information
- National Cancer Institute’s (NCI's) CISNET Lung Consortium (U01-CA199284)
This publication has 42 references indexed in Scilit:
- Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2014
- Patterns of Birth Cohort–Specific Smoking Histories, 1965–2009American Journal of Preventive Medicine, 2014
- Selection Criteria for Lung-Cancer ScreeningThe New England Journal of Medicine, 2013
- Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung CancerAnnals of Internal Medicine, 2012
- Chapter 7: Description of MISCAN‐Lung, the Erasmus MC Lung Cancer Microsimulation Model for Evaluating Cancer Control InterventionsRisk Analysis, 2012
- Chapter 8: The FHCRC Lung Cancer ModelRisk Analysis, 2012
- Chapter 9: The MGH‐HMS Lung Cancer Policy Model: Tobacco Control Versus ScreeningRisk Analysis, 2012
- Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history modelCancer Causes & Control, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- Analysis of lung cancer incidence in the nurses’ health and the health professionals’ follow-up studies using a multistage carcinogenesis modelCancer Causes & Control, 2007